GLP-1RA类药物的市场分析  

Market analysis of GLP-1RA drugs

作　　者：吴明洋 王亚超 华卉[1] WU Mingyang;WANG Yachao;HUA Hui(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing 210000,China;Eli Lilly(Suzhou)Pharmaceutical Co.,Ltd.,Suzhou 215126,China)

机构地区：[1]中国药科大学国际医药商学院,南京210000 [2]礼来(苏州)制药有限公司,苏州215126

出　　处：《上海医药》2022年第7期88-91,共4页Shanghai Medical & Pharmaceutical Journal

摘　　要：目的:对新型注射类降糖药GLP-1RA类药物进行市场分析,以求GLP-1RA类药物可以充分发挥市场潜力,提升市场影响力。方法:运用灰色系统理论均值GM(1,1)模型对GLP-1RA类药物未来5年的全球销售额进行预测,分析其在目前市场中存在的问题,并提出相关建议。结果:未来5年GLP-1RA类药物在全球市场的销售额将一直呈上升趋势,预计到2024年,可达到34849.34百万美元。结论:伴随着疗效以及产品设计的提升,加以精准的市场策略,GLP-1RA类药物未来必将成为糖尿病药物治疗领域的重要产品。Objective:To analyze the market of the new injectable hypoglycemic drugs GLP-1RA in order to give full play to the market potential and enhance the market influence.Methods:Grey system theory mean GM(1,1)model was used to predict the global sales of GLP-1RA drugs in the next five years,the existing problems in the current market were analyze and the relevant suggestions were proposed.Results:Global sales of GLP-1RA drugs were expected to increase over the next five years,reaching 34849.34 million dollars by 2024.Conclusion:With the improvement of efficacy and the product design and precise market strategy,GLP-1RA drugs will surely become an important product in the field of diabetes drug therapy in the future.

关 键 词：GLP-1RA 类药物 市场现状 灰色理论模型 市场预测 

分 类 号：F763[经济管理—产业经济] R977.15[医药卫生—药品]